Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Labiotech.eu

19:57 EDT 21st August 2018 | BioPortfolio

Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.

More Information about Labiotech.eu on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.

Showing News Articles 1–25 of 1,300+ from Labiotech.eu

Tuesday 21st August 2018

Update: Adocia Wins First Claim Against Eli Lilly for Disputed Milestone

Update: Adocia won its first claim against Eli Lilly & Company regarding a disputed milestone payment for development of a fast-acting insulin and has been awarded $11.6M (€10.1M) by the US Arbitration Panel assessing the case. Lilly had initially refused ... The post Update: Adocia Wins First Claim Against Eli Lilly for Disputed Milestone appeared first on Labiotech.eu.

Monday 20th August 2018

White Paper: Antibodies Through The Magnifying Glass

Download your free copy of this beautiful white paper we created with Scientist.com here! The post White Paper: Antibodies Through The Magnifying Glass appeared first on Labiotech.eu.

Labiotech’s 10 Favorite Biotech Books

Here is a list of our 10 best biotech books for you, ranging from new and classic popular science to science fiction, as selected by the team at Labiotech. The summer is sadly coming to a close very soon, but we wanted ... The post Labiotech’s 10 Favorite Biotech Books appeared first on Labiotech.eu.

Friday 17th August 2018

Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M

Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that act in response to changes in blood sugar levels. The Danish big-pharma, which is already a big player in the diabetes space, acquired the full ... The post Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M appeared first on Labiotech.eu.

This Italian Biotech Makes Wood-Derived Bone Implants

Today, we’re in Faenza, Italy, visiting GreenBone, a biotech developing wood-derived bone implants for patients with bone fractures. Mission: Founded in 2014, GreenBone takes bamboo and converts it to a calcium compound called hydroxyapatite. The material could be used as ... The post This Italian Biotech Makes Wood-Derived Bone Implants appeared first on Labiotech.eu.

Thursday 16th August 2018

Pfizer Offers €374M for German mRNA Flu Vaccine

BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to $425M (€374M) to develop an mRNA-based flu vaccine, which could be produced much more quickly than current flu vaccines. Messenger RNA (mRNA) is one of ... The post Pfizer Offers €374M for German mRNA Flu Vaccine appeared first on Labiotech.eu.

Wednesday 15th August 2018

London Biotech Gets Positive Phase III Results for its Monthly HIV Treatment

ViiV Healthcare has shown its monthly two-drug HIV treatment works as well as a daily three-drug treatment, which could help reduce the total number of drugs taken by patients. In a Phase III trial that recruited 618 people, London biotech ... The post London Biotech Gets Positive Phase III Results for its Monthly HIV Treatment appeared first on Labiotech.eu.

“The Biotech World is Very Well Connected, Don’t Mess Up”

This was some of the best advice I received at university from my masters director. A few years later I cannot agree more and I’m always surprised by how many people are not fully aware of it. Here is why! ... The post “The Biotech World is Very Well Connected, Don’t Mess Up” appeared first on Labiotech.eu.

Monday 13th August 2018

Orchard Therapeutics Raises €132M to Develop Gene Therapies

Orchard Therapeutics raised  $150M (€132M) in Series C financing to bring its gene therapies from clinical testing to regulatory approval. The British biotech will use the funding to develop its most advanced clinical programs, which aim to treat rare inherited ... The post Orchard Therapeutics Raises €132M to Develop Gene Therapies appeared first on Labiotech.eu.

5 DIY Biology Experiments You Can Do at Home

Here are five easy home experiments to have fun with biology without the need for expensive equipment. Biology is extremely exciting, but not all of us have access to state-of-the-art laboratory equipment to do biology experiments. However, it is possible ... The post 5 DIY Biology Experiments You Can Do at Home appeared first on Labiotech.eu.

Saturday 11th August 2018

Culturing Bacteria in a Lifesize Human Body Sculpture

Artist Melissa Fisher built a human sculpture carrying the myriad of invisible bacteria that live on our bodies to highlight the global threat of antibiotic resistance.  Journalist Michael Mosley enters the lab and sees a replica of his own body. ... The post Culturing Bacteria in a Lifesize Human Body Sculpture appeared first on Labiotech.eu.

Friday 10th August 2018

More news! Transplants, Parkinson’s, Nasal Vaccines, and More…

Try as we might, we can’t cover all the biotech news out there! It’s summer, so the news is thinner on the ground than usual, but here’s a roundup of news that didn’t make the cut this week. Swedish Hansa ... The post More news! Transplants, Parkinson’s, Nasal Vaccines, and More… appeared first on Labiotech.eu.

UK Biotech Raises €73M to Target DNA Repair in Treating Cancer

Artios Pharma completed a €73M (£65M) Series B financing round to develop cancer treatments that target DNA repair mechanisms. Cancer occurs when cells in part of the body start dividing uncontrollably as a result of damaged or mutated DNA. In ... The post UK Biotech Raises €73M to Target DNA Repair in Treating Cancer appeared first on Labiotech.eu.

This French Biotech Aims to Degrade Chemical Warfare Agents With Enzymes

Today, we’re in Marseille, visiting Gene & Green TK, a biotech that is developing enzymes that degrade insecticides and chemical warfare agents. Mission: Gene & Green’s enzymes are produced by hyperthermophilic microorganisms that live in environments with extremely high temperatures. ... The post This French Biotech Aims to Degrade Chemical Warfare Agents With Enzymes appeared fir...

Thursday 9th August 2018

Modulating the Microbiome Could Boost Vaccine Performance

Dutch scientists have found that altering a patient’s microbiome with antibiotics before a vaccination can boost the body’s resulting immune response against rotavirus infection. Rotavirus causes severe vomiting and diarrhea and largely affects children. Over 200,000 children are killed by ... The post Modulating the Microbiome Could Boost Vaccine Performance appeared first on Labiotech.eu.

Tuesday 7th August 2018

First 3D Placenta Model Helps Study Pregnancy Disorders

Austrian researchers have created a miniature 3D model of the human placenta, which could help us understand the causes of pregnancy complications. The human placenta plays a vital role in maintaining a healthy pregnancy, supplying the fetus with the nutrients ... The post First 3D Placenta Model Helps Study Pregnancy Disorders appeared first on Labiotech.eu.

Update: Seaweed-Derived Treatment for Common Cold Approved in the EU

Update (07/08/2018): Marinomed Biotech has obtained EU approval to sell a nasal spray containing a polymer derived from red seaweed that can trap most common cold viruses to stop them from infecting us.  Published on 19/07/2018 Marinomed Biotech’s antiviral treatment, ... The post Update: Seaweed-Derived Treatment for Common Cold Approved in the EU appeared first on Labiotech.eu.

Monday 6th August 2018

New Gene Therapy Could Treat Cystic Fibrosis With One Dose

A new partnership in the UK will develop a gene therapy for cystic fibrosis that could treat the disease with a single dose. Cystic fibrosis is a genetic disease that causes mucus to build up in a patient’s lungs. As ... The post New Gene Therapy Could Treat Cystic Fibrosis With One Dose appeared first on Labiotech.eu.

The 7 Do’s and Don’ts of Biotech Partnerships

The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it can be easy for a small company to underestimate the resources it needs to put into a successful collaboration. Here, ... The post The 7 Do’s and Don’ts of Biotech Partnerships appeared first on Labiotech.eu.

Saturday 4th August 2018

Linen and Bacteria: The Hidden History of Microbiology

A bioart exhibition explores the essential role that linen has played in the science of microbiology throughout history. Along with beer, linen is one of the oldest biotechnological products. Since its origins in ancient Egypt, bacteria have been responsible for ... The post Linen and Bacteria: The Hidden History of Microbiology appeared first on Labiotech.eu.

Friday 3rd August 2018

Precision Antibiotic Improves Outcome of Gut Infections in Phase II

Summit Therapeutics obtained Phase II results showing its antibiotic for C. difficile infections was more effective in reducing the recurrence of the disease than the standard of care. Clostridium difficile is a bacterium that can infect the gut after a ... The post Precision Antibiotic Improves Outcome of Gut Infections in Phase II appeared first on Labiotech.eu.

More News! Artificial Hearts, Sustainable Biofuels & More

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week. German biotech 4SC has launched a Phase Ib/II study of its small molecule drug candidate ... The post More News! Artificial Hearts, Sustainable Biofuels & More appeared first on Labiotech.eu.

This Biotech Targets the Neuronal Causes of Hearing Loss

Today, we’re in Archamps, France, visiting Pragma Therapeutics, a neuroscience biotech developing drugs to regulate neuronal signalling in hearing loss. Mission: Pragma Therapeutics develops treatments for noise-induced and age-related hearing loss that regulate glutamate levels. Glutamate is the most abundant neurotransmitter ... The post This Biotech Targets the Neuronal Causes of Hearing Los...

Thursday 2nd August 2018

Tomato DNA Could Help Uncover Counterfeit Breast Implants

Counterfeit breast implants can harm patients’ health and even threaten their lives. A German research team is using tomato DNA tags to tell the ‘real thing’ apart from frauds. The silicone used in implants need to have a high-quality to ... The post Tomato DNA Could Help Uncover Counterfeit Breast Implants appeared first on Labiotech.eu.

EMA Temporarily Scales Back Activities to Prepare for Brexit

As a result of Brexit, the European Medicines Agency will suspend some of its activities to prepare for staff cuts and its move from London to Amsterdam next year. As of October 1st, the EMA will cut back on international ... The post EMA Temporarily Scales Back Activities to Prepare for Brexit appeared first on Labiotech.eu.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks